Vimarsana
Biggest News Aggregation in the World

Page 6 - Consensus Decision Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Consensus Decision Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Consensus Decision Pathway Today - Breaking & Trending Today

How athletes can return to exercise after COVID-19 infection: New guidance released - Vimarsana News

How athletes can return to exercise after COVID-19 infection: New guidance released

WBAL Radio 1090 AM - How athletes can return to exercise after COVID-19 infection: New guidance released

Source: wbal.com
New ACC Guidance on Cardiovascular Consequences of COVID-19 - Vimarsana News

New ACC Guidance on Cardiovascular Consequences of COVID-19

A new consensus document makes recommendations on how to evaluate and manage COVID-associated myocarditis and long COVID; it also gives advice on when exercise can be resumed after COVID-19 infection.

How athletes can return to exercise after COVID-19 infection: New guidance released - Vimarsana News

How athletes can return to exercise after COVID-19 infection: New guidance released

The American College of Cardiology released new guidance for how athletes can return to exercise following a COVID-19 infection.

Source: go.com
Endotronix, Inc.: Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study - Vimarsana News

Endotronix, Inc.: Endotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study

Amended study design provides immediate access and clinical benefits for all patients and becomes the first global IDE study for PA pressure-guided heart failure management LISLE

ACC, Novo Nordisk to advance care for people with type 2 diabetes, cardiovascular disease - Vimarsana News

ACC, Novo Nordisk to advance care for people with type 2 diabetes, cardiovascular disease

 E-Mail The American College of Cardiology (ACC), in collaboration with Novo Nordisk A/S, today announced a new global program to support improvements in multidisciplinary care for people with Type 2 diabetes. Through the global UNITE (Multidisciplinary Teams In Cardiometabolic Care) program, clinicians across multiple specialties will receive the education and tools needed for an integrated approach to Type 2 diabetes and cardiovascular disease care. "Despite advances in care, people with Type 2 diabetes continue to face a higher risk of death and disability from cardiovascular disease," s...